Publications by authors named "Imogen A Ball"

Claim this Profile
A
Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study.
Anna Li, Joanne M Bowen, Imogen A Ball, Sophie Wilson, Angelina Yong

Biomedicines· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.
Samantha K Korver, Joanne M Bowen, Rachel J Gibson, Imogen A Ball, Kate R Secombe

Cancer Chemother Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats.
Kate R Secombe, Imogen A Ball, Anthony D Wignall, Emma Bateman, Dorothy M Keefe

Neoplasia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant.
Kate R Secombe, Imogen A Ball, Joseph Shirren, Anthony D Wignall, Dorothy M Keefe

Breast Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Karen Chiam, George C Mayne, Tingting Wang, David I Watson, Tanya S Irvine, Imogen A Ball

World J Gastroenterol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.
Kate R Secombe, Imogen A Ball, Joseph Shirren, Anthony D Wignall, John Finnie

Cancer Chemother Pharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective MMP Inhibition, Using AZD3342, to Reduce Gastrointestinal Toxicity and Enhance Chemoefficacy in a Rat Model.
Rachel J Gibson, Ysabella Z A van Sebille, Hannah R Wardill, Anthony Wignall, Joseph Shirren, Imogen A Ball

Chemotherapy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
Ysabella Z A Van Sebille, Rachel J Gibson, Hannah R Wardill, Imogen A Ball, Dorothy M K Keefe

Int J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
Ysabella Z A Van Sebille, Rachel J Gibson, Hannah R Wardill, Kate R Secombe, Imogen A Ball

Int J Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report.
Janet K Coller, Joanne M Bowen, Imogen A Ball, Hannah R Wardill, Ysabella Z A van Sebille

Cancer Chemother Pharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea.
Hannah R Wardill, Joanne M Bowen, Ysabella Z A Van Sebille, Kate R Secombe, Janet K Coller, Imogen A Ball

Mol Cancer Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis